ResearchMoz

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-08-30
No. Of Pages » 84
 
 This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). 
   
 The report also contains a section on...
Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 List Of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies
3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine
3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs
3.2.4 Increasing Cancer Incidence Worldwide
3.2.5 Impact Analysis Of Market Drivers
3.3 Market Restraints
3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies
3.3.2 Prolonged Developmental And Approval Phases
3.3.3 Impact Analysis Of Market Restraints
3.4 Market Opportunities
3.4.1 Expansion Into Newer Indication Areas
3.5 Porter’s Five Force Analysis: Global Companion Diagnostics Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012

Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million)
4.1 Introduction
4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %)
4.1.2 Breast Cancer
4.1.3 Lung Cancer
4.1.4 Colorectal Cancer
4.1.5 Gastric Cancer
4.1.6 Melanoma
4.1.7 Others (HIV, Thalassemia)

Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.5 Rest Of The World (Row)
5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share By Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers
7.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agendia N.V.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Recent Developments
8.3 Agilent Technologies, Inc.,
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Biogenex Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Recent Developments
8.5 Ge Healthcare Ltd.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Genomic Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Laboratory Corporation Of America Holdings (Labcorp)
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Qiagen N.V.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Resonance Health Analysis Services Pty Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Business Strategies
8.10.4 Recent Developments
8.11 Roche Holdings Ag
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Siemens Healthcare
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments

List of Tables


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Companion Diagnostics Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Companion Diagnostics Market, by Indications, Size and Forecast, 2011 - 2019 (USD Million)
TABLE 6 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)

List of Figures


FIG. 1 Companion Diagnostics Market Segmentation
FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Companion Diagnostics Market
FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indications, 2012 & 2019 (Value %)
FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %)
FIG. 13 North American Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 14 European Market for Companion Diagnostics, Size and Forecast, 2011– 2019 (USD Million)
FIG. 15 Asia-Pacific Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 16 RoW Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 17 Market Share Analysis: Companion Diagnostics Market, 2012 (%)
FIG. 18 Annual Revenues: Abbott Laboratories,  2010–2012 (USD Million)
FIG. 19 Annual Revenues: Agilent Technologies, Inc., 2010–2012 (USD Million)
FIG. 20 Annual Revenues: GE Healthcare, 2010–2012 (USD Million)
FIG. 21 Annual Revenues: Genomic Health, Inc.,  2010–2012 (USD Million)
FIG. 22 Annual Revenues: LabCorp,  2010–2012 (USD Million)
FIG. 23 Annual Revenues: Life Technologies Corporation, 2010–2012 (USD Million)
FIG. 24 Annual Sales: Qiagen N.V., 2010–2012 (USD Million)
FIG. 25 Annual Revenues: Roche Holdings AG, 2010–2012 (USD Million) (1Swiss Franc = 1.09 USD) (USD Million)
FIG. 26 Annual Revenues: Siemens Healthcare, 2010–2012 (USD Million)

Upcoming Reports:

Disposable Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Disposable syringes are widely used by physicians and patients at home in diagnosis and monitoring diseased conditions, along with administering medicines. Disposable syringes offer advantages over non-disposable with respect to cost, safety, ease of use and hygiene. The product segments of the global disposable syringes market include auto-disable syringes, auto-retractable safety syringes, single use syringes, insulin syringes and pen injectors, advanced injection devices, needle-free injectors, and others such as pre-filled syringes, blood collection needles and vaccination...
Greece: ice cream market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the ice cream market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the ice cream market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Barite Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Barite also known as barite or barium sulfate is among the abundantly available minerals. The mineral is available in various colors and is available as transparent or opaque and is crystalline in nature. Barite deposits can be bifurcated into three major types namely vein & cavity fillings, residual and bedded.  Vein & cavity fillings generally comprise of barite deposited from hydrothermal fluids, deep seated brines. Mining barite from vein & cavity fillings is a complex and an expensive procedure and it is predominantly extracted as a byproduct...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...